Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sublingual Sufentanil in Suboxone Patients Undergoing Ambulatory Surgery
NCT04716413Phase 4Terminated
- Sponsor
- Montefiore Medical Center
- Start
- Sep 2021
- Primary completion
- Nov 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of sufentanil in acute pain, sponsored by Montefiore Medical Center. Started Sep 2021; status: terminated.
02
Drugs
sufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT04716413.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04716413.